前列腺癌术后放疗后下肢淋巴水肿的发生率与预测因素
本研究评估前列腺癌根治性前列腺切除术(RP)±盆腔淋巴结清扫(PLND)后辅助或挽救性放疗(RT)患者下肢淋巴水肿(LEL)的发生率与预测因素,共101例,LEL定义为双肢体周径测量体积差≥10%。14例(13.9%)发生LEL,其中放疗前3例(2.9%)、放疗后11例(10.8%)。多因素分析显示糖尿病(OR=32.8,p=0.02)、手术至RT时间(OR=0.966,p=0.039)和运动(OR=0.03,p=0.002)与LEL独立相关。
要点
- 101例前列腺癌RP±PLND后放疗患者中14例(13.9%)发生下肢淋巴水肿,放疗后11例(10.8%)。
- 多因素分析中糖尿病(OR=32.8,p=0.02)、手术至RT时间(OR=0.966,p=0.039)和运动(OR=0.03,p=0.002)与LEL独立相关。
- 淋巴结检出数在单因素分析中与LEL高度相关(OR=1.066,p=0.025),但多因素分析未证实(p=0.719)。
核心结论
- 临床可检测的下肢淋巴水肿仅见于少数放疗后前列腺癌患者,糖尿病为易感因素,等待放疗实施对LEL具有保护作用,支持挽救性放疗优于辅助放疗。
研究设计与样本
- 纳入RP±PLND后接受辅助或挽救性RT且至少随访2年的前列腺癌患者,共101例。
- LEL定义为使用柔性非拉伸卷尺周径测量评估的双肢体体积差≥10%。
- 采用逻辑回归分析年龄、BMI、运动水平、吸烟、吸烟包年、高血压、血管合并症、糖尿病、PLND、检出淋巴结数、全盆腔放疗(WPRT)、RP至RT时间、PTV体积、PTV/BMI等预测因素,以p<0.05为统计显著。
主要发现
- 101例患者中14例(13.9%)发生LEL,其中放疗前3例(2.9%),放疗后11例(10.8%)。
- 手术至RT中位时间36.1个月(IQR:15.0-68.3),RT至研究检查日期中位时间51.1个月(IQR:36.8-65.3)。
- RT至LEL中位时间4个月(IQR:0.5-17.3)。
- 多因素分析显示糖尿病(OR=32.8,p=0.02)、手术至RT时间(OR=0.966,p=0.039)和运动(OR=0.03,p=0.002)与LEL独立相关。
- 淋巴结检出数在单因素分析中与LEL高度相关(OR=1.066,p=0.025),但多因素分析未证实(p=0.719);低运动水平患者检出淋巴结中位数12枚 vs 中/高运动水平患者5枚(p=0.034)。
关键数值与推荐
- LEL定义:双肢体周径测量体积差≥10%。
- 统计显著性阈值:p<0.05。
- 多因素分析中糖尿病OR=32.8(p=0.02),手术至RT时间OR=0.966(p=0.039),运动OR=0.03(p=0.002)。
临床怎么用
- 前列腺癌RP±PLND后放疗患者中,临床可检测的LEL见于少数患者,糖尿病为易感因素,等待RT实施对LEL具有保护作用,支持挽救性放疗优于辅助放疗。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess the rate and predictors of lower extremity lymphedema (LEL) after radiotherapy (RT) following radical prostatectomy (RP) ± pelvic lymph node dissection (PLND) for prostate cancer. METHODS: Patients (pts) treated with adjuvant or salvage RT after RP ± PLND and a minimum 2-year follow-up were included. LEL was defined as a volume difference ≥ 10% between limbs evaluated using circumferential measurements with a flexible non-stretch tape. The following predictors were investigated at logistic regression: age (continuous); body mass index (BMI, continuous); exercise level (low vs. medium/high); smoking (yes vs. no); cigarette pack/year (continuous); hypertension (yes ns no); vascular comorbidity (yes vs. no); diabetes (yes vs. no); PLND (yes vs. no); number of examined nodes (continuous); whole pelvis radiotherapy (WPRT) (yes vs. no); time between RP and RT (continuous); planning target volume (PTV) volume (continuous); PTV/BMI (continuous). Statistical significance was claimed for p < 0.05. RESULTS: 101 pts were examined. The median time from surgery to RT was 36.1 months (mths) (IQR: 15.0-68.3), the median time from RT to the date of study examination was 51.1 months (IQR: 36.8-65.3). 14 pts developed LEL (13.9%), 3 pts (2.9%) before RT, 11 pts (10.8%) after RT. The median time from RT to LEL was 4 mths (IQR: 0.5-17.3). At multivariable analysis (MVA) diabetes mellitus (DM) (OR = 32.8, p = 0.02), time between surgery and RT (OR = 0.966, p = 0.039) and exercise (OR = 0.03, p = 0.002) were independently correlated to LEL. The number of examined nodes was highly correlated to LEL at univariate analysis (OR = 1.066, p = 0.025) but was not confirmed at MVA (p = 0.719). Interestingly, the distribution of the examined nodes was statistically different between pts with low (median N = 12) vs. medium/high (N = 5) exercise (p = 0.034). CONCLUSIONS: Clinically detectable LEL involves a minority of pts after RT. DM is a predisposing factor, while awaiting RT delivery has a protective effect favoring salvage over adjuvant RT.
引用
- Facondo G, Bottero M, Goanta L, et al. Incidence and predictors of lower extremity lymphedema after postoperative radiotherapy for prostate cancer. Radiat Oncol. 2025. PMID: 40102881. doi:10.1186/s13014-025-02599-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。